JUNCTURE WEALTH STRATEGIES, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1632866 SCOTTSDALE, AZ

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$886,857

+$288,363 QoQ

Shares Held

5,262

+15.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

1.27%

of 13F equity value

Holder Rank

#417

of 772 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JUNCTURE WEALTH STRATEGIES, LLC holds $3,368,884 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (26.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	17,824	$1,139,844
2	ETON	Eton Pharmaceuticals, Inc.	28,849	$1,044,333
3	NBIX	Neurocrine Biosciences Inc This page	5,262	$886,857
4	SUPN	Supernus Pharmaceuticals, Inc.	6,404	$297,850

All Filings in NBIX

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$886,857	5,262	+15.8%	Shares	Sole	2026-07-09
2026-03-31	$598,494	4,543	-5.3%	Shares	Sole	2026-04-15
2025-12-31	$680,216	4,796	+2.7%	Shares	Sole	2026-01-27
2025-09-30	$655,714	4,671	+17.2%	Shares	Sole	2025-10-14
2025-06-30	$501,126	3,987	-41.0%	Shares	Sole	2025-07-08
2025-03-31	$746,881	6,753	-7.3%	Shares	Sole	2025-04-10
2024-12-31	$993,993	7,282	-13.3%	Shares	Sole	2025-01-21
2024-09-30	$967,617	8,398	-2.3%	Shares	Sole	2024-10-09
2024-06-30	$1,183,686	8,598	+2.1%	Shares	Sole	2024-07-11
2024-03-31	$1,161,976	8,425	+4.2%	Shares	Sole	2024-04-05
2023-12-31	$1,064,884	8,082	—	Shares	Sole	2024-01-08
No filing history on record for this holder in this stock.